SCHEMBL468282

SCHEMBL468282

NC1CC=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL471704 1.00
SCHEMBL471705 1.00
Hydrochloric Acid SCHEMBL9978591 0.97
Hydrochloric Acid SCHEMBL9980432 0.97
SCHEMBL470793 0.83
SCHEMBL17928983 0.82
SCHEMBL11825568 0.82
SCHEMBL21261786 0.80
SCHEMBL19445459 0.80
SCHEMBL13357074 0.78 THRB (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118702932-A Light-responsive hydrogel and preparation method and application thereof 至微(深圳)医学科技有限公司 2024-09-27 CN claimed
EP-1127872-B1 Tamiflu via Diels-Alder HOFFMANN LA ROCHE (CH) 2006-02-01 EP claimed
US-6403824-B2 NEURAMINIDASE INHIBITORS HOFFMANN-LA ROCHE INC. 2002-06-11 US claimed
US-20020006960-A1 Process for the preparation fo 4,5-diamino shikimic acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 2002-01-17 US claimed
EP-1127872-A1 Tamiflu via Diels-Alder F. HOFFMANN-LA ROCHE AG (CH) 2001-08-29 EP claimed
CN-1186072-A Synthesis of dicyclic 3-alkyl methylene-2-proolidone derivatives GUANGZHOU CHEMISTRY INST CAS (CN) 1998-07-01 CN claimed
EP-3860636-B1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE INC (US) 2026-01-28 EP disclosed
US-12428415-B2 Matriptase 2 inhibitors and uses thereof DISC MEDICINE, INC. (US) 2025-09-30 US disclosed
CN-118922209-A Cross-linked antibodies 恩拉扎治疗公司 2024-11-08 CN disclosed
CN-118702932-A Light-responsive hydrogel and preparation method and application thereof 至微(深圳)医学科技有限公司 2024-09-27 CN disclosed
CN-113795254-B Pyrazolopyridine compounds for IRE1 inhibition 奥普提卡拉公司 2024-08-09 CN disclosed
CN-112778183-B Nitrogen-containing ring derivative regulator, preparation method and application thereof 江苏豪森药业集团有限公司 2024-05-10 CN disclosed
US-11916195-B2 Electrolyte solution, electrochemical device, lithium ion secondary battery, and module DAIKIN INDUSTRIES, LTD. (JP) 2024-02-27 US disclosed
EP-0100898-B1 CYCLOALKYL DERIVATIVES OF BENZISOSELENAZOLONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM A. Nattermann & Cie. GmbH (DE) 1987-05-13 EP disclosed
EP-0113028-B1 SUBSTITUED BENZYLCYCLOALKENYL UREA DERIVATIVES NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1986-04-30 EP disclosed
EP-0128006-A2 A soil-disease-controlling agent SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-12-12 EP disclosed
EP-0113028-A1 Substitued benzylcycloalkenyl urea derivatives NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1984-07-11 EP disclosed
US-4454068-A Cycloalkyl derivatives of benzisoselenazolones A. NATTERMANN & CIE GMBH (DE) 1984-06-12 US disclosed
EP-0100898-A1 Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them A. Nattermann & Cie. GmbH (DE) 1984-02-22 EP disclosed
US-3932503-A Benzenesulfonyl ureas HOECHST AKTIENGESELLSCHAFT (DT) 1976-01-13 US disclosed